Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 300.00
Bid: 298.50
Ask: 301.50
Change: 13.00 (4.53%)
Spread: 3.00 (1.005%)
Open: 280.50
High: 304.50
Low: 280.50
Prev. Close: 287.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS: Deutsche raises GSK; HSBC cuts BP to Hold

Thu, 24th Jun 2021 09:49

(Alliance News) - The following London-listed shares received analyst recommendations Thursday and Wednesday:

----------

FTSE 100

----------

DEUTSCHE BANK RAISES GLAXOSMITHKLINE TO 'HOLD' (SELL) - PRICE TARGET 1,350 (1,300) PENCE

----------

CREDIT SUISSE RAISES GLAXOSMITHKLINE PRICE TARGET TO 1,400 (1,300) PENCE - 'UNDERPERFORM'

----------

UBS RAISES SAINSBURY PRICE TARGET TO 290 (275) PENCE - 'BUY'

----------

BOFA RAISES DIAGEO PRICE TARGET TO 4,150 (3,900) PENCE - 'BUY'

----------

BERENBERG RAISES CRODA INTERNATIONAL PRICE TARGET TO 7,800 (7,400) PENCE - 'BUY'

----------

BERENBERG INITIATES PHOENIX GROUP WITH 'HOLD' - TARGET 790 PENCE

----------

CREDIT SUISSE RAISES NATWEST PRICE TARGET TO 260 (247) PENCE - 'OUTPERFORM'

----------

UBS RAISES BERKELEY GROUP PRICE TARGET TO 5,400 (5,240) PENCE - 'BUY'

----------

JEFFERIES CUTS CRH PRICE TARGET TO 4,449 (4,549) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES DS SMITH PRICE TARGET TO 470 (450) PENCE - 'NEUTRAL'

----------

HSBC CUTS BP TO 'HOLD' (BUY) - PRICE TARGET 360 (365) PENCE

----------

CREDIT SUISSE CUTS SEVERN TRENT PRICE TARGET TO 2,310 (2,340) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

HSBC RAISES IMI TO 'BUY' ('HOLD') - TARGET 2,065 (1,370) PENCE

----------

JPMORGAN CUTS WOOD GROUP PRICE TARGET TO 340 (350) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES TRAVIS PERKINS PRICE TARGET TO 2050 (1910) PENCE - 'BUY'

----------

BERNSTEIN RAISES ROYAL MAIL PRICE TARGET TO 650 (575) PENCE - 'MARKET-PERFORM'

----------

BERENBERG INITIATES BEAZLEY WITH 'HOLD' - TARGET 410 PENCE

----------

BERENBERG RAISES CINEWORLD GROUP PRICE TARGET TO 85 (70) PENCE - 'HOLD'

----------

BARCLAYS RAISES WORKSPACE GROUP PRICE TARGET TO 745 (700) PENCE - 'UNDERWEIGHT'

----------

JEFFERIES RAISES OXFORD BIOMEDICA PRICE TARGET TO 1,180 (950) PENCE - 'HOLD'

----------

OTHER MAIN MARKET AND AIM

----------

BERENBERG RAISES NEXT FIFTEEN COMMUNICATIONS TARGET TO 1,140 (940) PENCE - 'BUY'

----------

JEFFERIES RAISES KERRY GROUP PRICE TARGET TO 130 (127) EUR - 'BUY'

----------

RBC RAISES SMART METERING PRICE TARGET TO 1,060 (950) PENCE - 'OUTPERFORM'

----------

BERENBERG RAISES VICTORIA PRICE TARGET TO 1,110 (1,050) PENCE - 'BUY'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
22 Apr 2022 09:21

LONDON BROKER RATINGS: RBC cuts Anglo American; Jefferies ups Berkeley

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday afternoon:

Read more
20 Apr 2022 17:11

LONDON MARKET CLOSE: Stocks up as G20 finance heads meet; Netflix down

(Alliance News) - Stocks in London ended higher on Wednesday as investors continued to track the war in Ukraine, while in the US, Netflix weighed on the tech-heavy Nasdaq index.

Read more
20 Apr 2022 12:11

LONDON MARKET MIDDAY: Europe pushes higher as Netflix shockwave wanes

(Alliance News) - The FTSE 100 index moved upwards with a bit more conviction as the morning progressed in London on Wednesday, shaking off a mixed US earnings season.

Read more
20 Apr 2022 10:00

Oxford BioMedica shares fall as warns on 2022 amid Covid jab pause

(Alliance News) - Oxford BioMedica PLC on Wednesday warned it will swing to a loss in 2022 and revenue will fall as Covid-19 vaccine manufacturing for AstraZeneca PLC will take a pause.

Read more
20 Apr 2022 09:10

Oxford Biomedica reports year of solid growth

(Sharecast News) - Oxford Biomedica reported a 63% improvement in total revenues in its preliminary results on Wednesday, to £142.8m, although its outlook was somewhat less rosy amid a pause in vaccine manufacturing.

Read more
13 Apr 2022 16:05

UK earnings, trading statements calendar - next 7 days

Thursday 14 April 
Ashmore Group PLCTrading Statement
Dunelm Group PLCTrading Statement
Hays PLCTrading Statement
Mediclinic International PLCTrading Statement
Ninety One PLC and LtdTrading Statement
Norcros PLCTrading Statement
Friday 15 April 
no events scheduled 
Monday 18 April 
no events scheduled 
Tuesday 19 April  
JTC PLCFull Year Results
Kainos Group PLCTrading Statement
Rio Tinto PLCQ1 Production Results
Wednesday 20 April  
Bunzl PLCTrading Statement
Carr's Group PLCHalf Year Results
Centamin PLCTrading Statement
Hunting PLCTrading Statement
IntegraFin Holdings PLCTrading Statement
John Wood Group PLCFull Year Results
Oxford Biomedica PLCFull Year Results
Petra Diamonds LtdTrading Statement
Quilter PLCTrading Statement
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
1 Feb 2022 09:37

LONDON BROKER RATINGS: Imperials Brands raised; HSBC likes Fevertree

LONDON BROKER RATINGS: Imperials Brands raised; HSBC likes Fevertree

Read more
1 Feb 2022 08:51

Oxford Biomedica affirms end to licensing deal with Sio Gene Therapies

Oxford Biomedica affirms end to licensing deal with Sio Gene Therapies

Read more
1 Feb 2022 07:40

Oxford Biomedica's Parkinson's licensee pulls out

(Sharecast News) - Oxford Biomedica's licensee for a Parkinson's disease treatment has pulled out of development and returned the rights to the UK company.

Read more
28 Jan 2022 19:17

UPDATE: Oxford BioMedica raises GBP80 million via placing

UPDATE: Oxford BioMedica raises GBP80 million via placing

Read more
28 Jan 2022 16:59

LONDON MARKET CLOSE: Stocks close out rollercoaster week with losses

LONDON MARKET CLOSE: Stocks close out rollercoaster week with losses

Read more
28 Jan 2022 16:19

CORRECT: Oxford BioMedica to acquire 80% ownership of new US business

CORRECT: Oxford BioMedica to acquire 80% ownership of new US business

Read more
28 Jan 2022 12:13

LONDON MARKET MIDDAY: Stocks sink on Ukraine tensions and hawkish Fed

LONDON MARKET MIDDAY: Stocks sink on Ukraine tensions and hawkish Fed

Read more
28 Jan 2022 10:27

Oxford BioMedica to acquire 80% ownership of new US virus business

Oxford BioMedica to acquire 80% ownership of new US virus business

Read more
28 Jan 2022 09:56

Oxford Biomedica creates venture with Homology, launches £80m fundraise

(Sharecast News) - Cell and gene therapy specialist Oxford Biomedica announced an agreement with Homology Medicines on Friday, as well as a placing to raise £80m from new and existing shareholders, including a retail offer through the PrimaryBid platform.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.